護理師與高齡個案討論帶狀疱疹疫苗。什麼資訊是正確的？
A nurse is counseling an older client about the shingles vaccine. What is the correct information?
- AIt provides lifelong protection after one dose接種一劑後可提供終身保護
- BIt should be given only after you have shingles應僅在罹患帶狀疱疹後接種
- CIt is not effective in preventing neuralgia無法有效預防神經痛
- DIt is recommended for adults 50 and older✓ 正解建議 50 歲以上成人接種
帶狀疱疹（Shingles）疫苗的主要目標是預防帶狀疱疹病毒再活化引起的疼痛及併發症。根據美國疾病管制與預防中心（CDC）指引，建議 50 歲以上的成人接種重組帶狀疱疹疫苗（Shingrix），即便過去曾患過帶狀疱疹或接種過舊型減毒疫苗者仍建議施打。臨床上，護理師應強調疫苗對預防帶狀疱疹後神經痛（Postherpetic Neuralgia, PHN）的重要性，這是最常見且嚴重的併發症。
The primary goal of the shingles vaccine is to prevent the pain and complications caused by reactivation of the varicella-zoster virus. According to U.S. CDC guidelines, the recombinant zoster vaccine (Shingrix) is recommended for adults 50 years of age and older, including those who have previously had shingles or have received the older live-attenuated vaccine. Clinically, the nurse should emphasize the vaccine's importance in preventing postherpetic neuralgia (PHN), which is the most common and serious complication.
美國目前全面推廣 Shingrix（重組疫苗），且納入常規成人疫苗接種計畫；台灣目前亦已引進 Shingrix，但在公費或自費接種的政策規劃及年齡建議上，建議需參考各縣市衛生局或疾管署最新公告。